Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The Science Behind Retatrutide's Triple Mechanism Each of retatrutide's three receptor targets contributes unique metabolic benefits: GIP Receptor Activation: Enhances insulin secretion in response to food intake Influences fat metabolism and storage patterns Modulates bone metabolism and cardiovascular function Complements GLP-1 effects for improved glycemic control GLP-1 Receptor Activation: Stimulates insulin release while suppressing glucagon Slows gastric emptying to extend satiety Reduces appetite through central nervous system pathways Provides cardiovascular protective effects Glucagon Receptor Activation: Increases energy expenditure and metabolic rate Promotes fat oxidation and lipolysis Helps prevent metabolic adaptation during weight loss Balances the anabolic effects of insulin signaling This triple-action approach explains why retatrutide demonstrated remarkable results in phase 2 clinical trials, with participants experiencing up to 24.2% body weight reduction at 48 weeks [4]
and (3) treat the stack as a timelimited therapeutic trial with objective endpoints, not a permanent lifestyle supplement
Energy restored
In vitro and animal-based studies have explored AOD-9604's interactions with osteoblast and osteoclast activity, investigating its role in bone remodeling pathways independent of IGF-1 signaling
US$ 22.96
US$ 22.34
US$ 21.60
US$ 20.54
US$ 26.83
US$ 26.71
US$ 24.58
US$ 20.52
US$ 24.50
US$ 20.08
